OFFICIAL PUBLICATION OF

by its subsidiary APPco

The COVID impact

Guest Author 11/07/2021

How has COVID affected pharmacy valuations? John Thornett gives his three key learnings to date from 2021 valuations You see there is this thing called COVID. You may have heard about it (I say this with most of Australia currently in lockdown.) In the world of valuations, it provided just another challenge amongst a whole

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

‘I can feel the walls closing in on me as this snowballs’

I agree Christine. HMRs and RMMRs are really the success story of advanced practice in Australia. They are supported by…

Debbie Rigby

The COVID impact

Previous Uncertainty over immunisation reporting

Next Vax approval as pharmacies contend with multiple cases

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Uncertainty over immunisation reporting

Next Vax approval as pharmacies contend with multiple cases

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.